ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Fasting plasma glucose in the first trimester is related to gestational diabetes mellitus and adverse pregnancy outcomes

Tong, Jia-Ning; Wu, Lin-Lin; Chen, Yi-Xuan; Guan, Xiao-Nian; Tian, Fu-Ying; Zhang, Hua-Fan; Liu, Kan; Yin, Ai-Qi; Wu, Xiao-Xia; Prof, Jian-Min Niu*南方医科大学; 1
ENDOCRINE2022-1DOI: 10.1007/s12020-021-02831-w
11被引6阅读
引用收藏
分享

摘要

Purpose To investigate and identify first-trimester fasting plasma glucose (FPG) is related to gestational diabetes mellitus (GDM) and other adverse pregnancy outcomes in Shenzhen population. @@@ Methods We used data of 48,444 pregnant women that had been retrospectively collected between 2017 and 2019. Logistic regression analysis was used to evaluated the associations between first-trimester FPG and GDM and adverse pregnancy outcomes, and used to construct a nomogram model for predicting the risk of GDM. The performance of the nomogram was evaluated by using ROC and calibration curves. Decision curve analysis (DCA) was used to determine the clinical usefulness of the first-trimester FPG by quantifying the net benefits at different threshold probabilities. @@@ Results The mean first-trimester FPG was 4.62 +/- 0.42 mmol/L. A total of 6998 (14.4%) pregnancies developed GDM.489(1.01%) pregnancies developed polyhydramnios, the prevalence rates of gestational hypertensive disorder (GHD), cesarean section, primary cesarean section, preterm delivery before 37 weeks (PD) and dystocia was 1130 (2.33%), 20,426 (42.16%), 7237 (14.94%), 2386 (4.93%), and 1865 (3.85%), respectively. 4233 (8.74%) of the newborns were LGA, and the number of macrosomia was 2272 (4.69%), LBW was 1701 (3.51%) and 5084 (10.49%) newborns had admission to the ICU, which all showed significances between GDM and non-GDM groups (all P < 0.05). The univariate analysis showed that first-trimester FPG was strongly associated with risks of outcomes including GDM, cesarean section, macrosomia, GHD, primary cesarean section, and LGA (all OR > 1, all P < 0.05), furthermore, the risks of GDM, primary cesarean section, and LGA was increasing with first-trimester FPG as early as it was at 4.19-4.63 mmol/L. The multivariable analysis showed that the risks of GDM (ORs for FPG 4.19-4.63, 4.63-5.11 and 5.11-7.0 mmol/L were 1.137, 1.592, and 4.031, respectively, all P < 0.05) increased as early as first-trimester FPG was at 4.19-4.63 mmol/L, and first-trimester FPG which was also associated with the risks of cesarean section, macrosomia and LGA (OR for FPG 5.11-7.0 mmol/L of cesarean section: 1.128; OR for FPG 5.11-7.0 mmol/L of macrosomia: 1.561; OR for FPG 4.63-5.11 and 5.11-7.0 mmol/L of LGA: 1.149 and 1.426, respectively, all P < 0.05) and with its increasing, the risks of LGA increased. Furthermore, the nomogram had a C-indices 0.771(95% CI: 0.763 similar to 0.779) and 0.770(95% CI:0.758 similar to 0.781) in training and testing validation respectively, which showed an acceptable consistency between the observed, validation and nomogram-predicted probabilities, the DAC curve analysis indicated that the nomogram had important clinical application value for GDM risk prediction. @@@ Conclusions FPG in the first trimester was an independent risk factor for GDM which can be used as a screening test for identifying pregnancies at risk of GDM and adverse pregnancy outcomes.

学科与关键词

关键词
The First Trimester FPGGDMMetabolic Diseases in PregnancyAdverse Pregnancy Outcomes
相关
加载中…
  • Association between the cut-off value of the first trimester fasting plasma glucose level and gestational diabetes mellitus: a retrospective study from southern China
    Tong, Jia-Ning; Chen, Yi-Xuan; Guan, Xiao-Nian; Liu, Kan; Yin, Ai-Qi; Zhang, Hua-Fan; Wu, Lin-Lin*; Niu, Jian-Min*BMC Pregnancy and Childbirth, 2022, 22(1): 540.被引 3
  • Evaluation of the value of fasting plasma glucose in the first prenatal visit to diagnose gestational diabetes mellitus in china.
    Zhu, Wei-Wei; Yang, Hui-Xia; Wei, Yu-Mei; Yan, Jie; Wang, Zi-Lian; Li, Xue-Lan; Wu, Hai-Rong; Li, Nan; Zhang, Mei-Hua; Liu, Xing-Hui; Zhang, Hua; Wang, Yun-Hui; Niu, Jian-Min; Gan, Yu-Jie; Zhong, Li-Ruo; Wang, Yun-Feng; Kapur, AnilDiabetes Care, 2013, 36(3): 586-590.
  • Maternal fasting glucose levels throughout the pregnancy and risk of adverse birth outcomes in newborns: a birth cohort study in Foshan city, Southern China
    Yang, Yin; Lin, Qingmei; Ma, Liming; Lai, Zhihan; Xie, Junxing; Zhang, Zilong; Wu, Xueli; Luo, Weidong; Hu, Pengzhen; Wang, Xing; Guo, Xiaoling*; Lin, Hualiang*European Journal of Endocrinology, 2023, 188(1): lvac019.
查看全部 →

发表信息

论文状态
公开发表
期刊
ENDOCRINE
发表日期
2022-01
卷期
第 75 卷, 第 1 期
页码
70-81
DOI
10.1007/s12020-021-02831-w
语言
ENGLISH
期刊等级
3区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81830041,81771611]; Shen Zhen Science and Technology Innovation Committee Special Funding for Future Industry [JCYJ20170412140326739]

作者

  • T

    Tong, Jia-Ning (第一作者)

    1 · shenzhen matern & child healthcare hosp · southern med univ

  • W

    Wu, Lin-Lin

    1 · shenzhen matern & child healthcare hosp · southern med univ

查看全部 10 位作者收起作者
  • C

    Chen, Yi-Xuan

    1 · shenzhen matern & child healthcare hosp · southern med univ

  • G

    Guan, Xiao-Nian

    1 · shenzhen matern & child healthcare hosp · southern med univ

  • T

    Tian, Fu-Ying

    1 · shenzhen matern & child healthcare hosp · southern med univ

  • Z

    Zhang, Hua-Fan

    1 · shenzhen matern & child healthcare hosp · southern med univ

  • L

    Liu, Kan

    1 · shenzhen matern & child healthcare hosp · southern med univ

  • Y

    Yin, Ai-Qi

    1 · shenzhen matern & child healthcare hosp · southern med univ

  • W

    Wu, Xiao-Xia

    1 · shenzhen matern & child healthcare hosp · southern med univ

  • P

    Prof, Jian-Min Niu (通讯)

    1 · shenzhen matern & child healthcare hosp · southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417